FDA Still Soliciting Applications For START Pilot As Deadline For Rare Disease Program Looms

 
• By Brenda Sandburg and Nielsen Hobbs

Agency anticipated receiving more applications for the program, which aims to bring Operation Warp Speed-like response to investigational rare disease therapies, than it has so far, though a last-minute ‘flood’ is still expected. CBER and CDER are accepting requests through 1 March.

Crossing finish line
FDA pilot program aims to get rare disease treatments across the finish line faster • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet